Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Operating Income 2011-2023 | ZTS

Zoetis annual/quarterly operating income history and growth rate from 2011 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Zoetis operating income for the quarter ending December 31, 2023 was $0.650B, a 9.8% increase year-over-year.
  • Zoetis operating income for the twelve months ending December 31, 2023 was $2.936B, a 10.54% increase year-over-year.
  • Zoetis annual operating income for 2023 was $2.936B, a 10.54% increase from 2022.
  • Zoetis annual operating income for 2022 was $2.656B, a 6.75% increase from 2021.
  • Zoetis annual operating income for 2021 was $2.488B, a 24.65% increase from 2020.
  
Zoetis Annual Operating Income
(Millions of US $)
2023 $2,936
2022 $2,656
2021 $2,488
2020 $1,996
2019 $1,801
2018 $1,690
2017 $1,525
2016 $1,228
2015 $545
2014 $820
2013 $690
2012 $710
2011 $394
2010 $178
Zoetis Quarterly Operating Income
(Millions of US $)
2023-12-31 $650
2023-09-30 $717
2023-06-30 $872
2023-03-31 $697
2022-12-31 $592
2022-09-30 $667
2022-06-30 $670
2022-03-31 $727
2021-12-31 $506
2021-09-30 $659
2021-06-30 $636
2021-03-31 $687
2020-12-31 $420
2020-09-30 $597
2020-06-30 $482
2020-03-31 $497
2019-12-31 $437
2019-09-30 $528
2019-06-30 $455
2019-03-31 $381
2018-12-31 $418
2018-09-30 $418
2018-06-30 $437
2018-03-31 $417
2017-12-31 $430
2017-09-30 $413
2017-06-30 $345
2017-03-31 $337
2016-12-31 $231
2016-09-30 $333
2016-06-30 $332
2016-03-31 $332
2015-12-31 $69
2015-09-30 $273
2015-06-30 $-27
2015-03-31 $230
2014-12-31 $155
2014-09-30 $238
2014-06-30 $200
2014-03-31 $227
2013-12-31 $126
2013-09-30 $185
2013-06-30 $187
2013-03-31 $192
2012-12-31 $82
2012-09-30 $213
2012-06-30 $252
2012-03-31 $171
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $69.985B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $54.581B 23.70
Takeda Pharmaceutical (TAK) Japan $41.871B 6.78
Merck (MKGAF) Germany $20.986B 19.80
Astellas Pharma (ALPMY) Japan $16.902B 23.95
Shionogi (SGIOY) Japan $14.275B 12.35
Neurocrine Biosciences (NBIX) United States $13.233B 54.96
Sandoz Group AG (SDZNY) $13.171B 0.00
United Therapeutics (UTHR) United States $10.907B 11.68
Catalent (CTLT) United States $10.095B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.501B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.861B 6.96
Ionis Pharmaceuticals (IONS) United States $6.055B 0.00
Revolution Medicines (RVMD) United States $5.970B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.341B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Madrigal Pharmaceuticals (MDGL) United States $4.636B 0.00
Alpine Immune Sciences (ALPN) United States $4.228B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.027B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.933B 0.00
Indivior (INDV) United States $2.673B 12.43
Evotec AG (EVO) Germany $2.484B 0.00
Summit Therapeutics (SMMT) United States $2.484B 0.00
Corcept Therapeutics (CORT) United States $2.421B 24.62
Dyne Therapeutics (DYN) United States $2.123B 0.00
PTC Therapeutics (PTCT) United States $1.937B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.834B 18.95
Fusion Pharmaceuticals (FUSN) Canada $1.804B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.776B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.741B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.673B 9.91
Avadel Pharmaceuticals (AVDL) Ireland $1.639B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.581B 27.66
Ardelyx (ARDX) United States $1.561B 0.00
4D Molecular Therapeutics (FDMT) United States $1.368B 0.00
Pacira BioSciences (PCRX) United States $1.249B 12.44
Ironwood Pharmaceuticals (IRWD) United States $1.235B 11.60
Soleno Therapeutics (SLNO) United States $1.227B 0.00
Ocular Therapeutix (OCUL) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.158B 7.12
Xencor (XNCR) United States $1.156B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.106B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.950B 0.00
Sage Therapeutics (SAGE) United States $0.939B 0.00
Cronos Group (CRON) Canada $0.932B 0.00
Cassava Sciences (SAVA) United States $0.909B 0.00
ARS Pharmaceuticals (SPRY) United States $0.886B 0.00
Relay Therapeutics (RLAY) United States $0.884B 0.00
Enliven Therapeutics (ELVN) United States $0.875B 0.00
USANA Health Sciences (USNA) United States $0.831B 13.09
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.723B 0.00
Savara (SVRA) United States $0.713B 0.00
Silence Therapeutics (SLN) United Kingdom $0.636B 0.00
Siga Technologies (SIGA) United States $0.635B 9.40
ProKidney (PROK) United States $0.624B 0.00
Lyell Immunopharma (LYEL) United States $0.612B 0.00
Verve Therapeutics (VERV) United States $0.597B 0.00
Korro Bio (KRRO) United States $0.589B 0.00
OmniAb (OABI) United States $0.565B 0.00
Altimmune (ALT) United States $0.533B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.530B 0.00
Exscientia (EXAI) United Kingdom $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.501B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.471B 0.00
Larimar Therapeutics (LRMR) United States $0.462B 0.00
Tourmaline Bio (TRML) United States $0.458B 0.00
Heron Therapeutics (HRTX) United States $0.440B 0.00
Harrow (HROW) United States $0.435B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.432B 0.00
Lexeo Therapeutics (LXEO) United States $0.403B 0.00
Organogenesis (ORGO) United States $0.377B 71.50
Bioventus (BVS) United States $0.367B 0.00
Esperion Therapeutics (ESPR) United States $0.362B 0.00
Nature's Sunshine Products (NATR) United States $0.356B 19.91
ESSA Pharma (EPIX) Canada $0.329B 0.00
Fractyl Health (GUTS) United States $0.327B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.325B 0.00
Lyra Therapeutics (LYRA) United States $0.323B 0.00
Metagenomi (MGX) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.297B 0.00
Akebia Therapeutics (AKBA) United States $0.293B 0.00
Aquestive Therapeutics (AQST) United States $0.282B 0.00
Black Diamond Therapeutics (BDTX) United States $0.278B 0.00
Adherex Technologies (FENC) United States $0.278B 0.00
Nektar Therapeutics (NKTR) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.273B 0.00
Prelude Therapeutics (PRLD) United States $0.270B 0.00
Nanobiotix S.A (NBTX) France $0.260B 0.00
Foghorn Therapeutics (FHTX) United States $0.257B 0.00
Xeris Biopharma Holdings (XERS) United States $0.253B 0.00
Avita Medical (RCEL) United States $0.249B 0.00
Telomir Pharmaceuticals (TELO) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.228B 0.00
Conduit Pharmaceuticals (CDT) United States $0.225B 0.00
Acrivon Therapeutics (ACRV) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Zevra Therapeutics (ZVRA) United States $0.207B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.191B 0.00
MediWound (MDWD) Israel $0.174B 0.00
Regulus Therapeutics (RGLS) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.156B 0.00
Incannex Healthcare (IXHL) Australia $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.150B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Inotiv (NOTV) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.53
GlycoMimetics (GLYC) United States $0.139B 0.00
Relmada Therapeutics (RLMD) United States $0.138B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.136B 2.87
ProPhase Labs (PRPH) United States $0.133B 0.00
FibroGen (FGEN) United States $0.128B 0.00
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
Eliem Therapeutics (ELYM) United States $0.126B 0.00
OptiNose (OPTN) United States $0.123B 0.00
Citius Pharmaceuticals (CTXR) United States $0.119B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Vivani Medical (VANI) United States $0.106B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
AlloVir (ALVR) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Journey Medical (DERM) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.076B 6.12
Tempest Therapeutics (TPST) United States $0.074B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Mural Oncology (MURA) $0.066B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.066B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.79
Gain Therapeutics (GANX) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
JanOne (JAN) United States $0.033B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Nutriband (NTRB) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.031B 0.00
Viracta Therapeutics (VIRX) United States $0.028B 0.00
Aptorum Group (APM) United Kingdom $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
CERo Therapeutics Holdings (CERO) United States $0.027B 0.00
Lipocine (LPCN) United States $0.025B 0.00
DURECT (DRRX) United States $0.024B 0.00
Addex Therapeutics (ADXN) Switzerland $0.024B 0.00
Indaptus Therapeutics (INDP) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.40
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 1.08
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
BioVie (BIVI) United States $0.019B 0.00
Surrozen (SRZN) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Clever Leaves Holdings (CLVR) Canada $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Finch Therapeutics (FNCH) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.92
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 46.73